2015\u5e7412\u670804\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
\u3000³Ô¹Ï±¬ÁÏ Systems Inc.\u3010NYSE:VEEV\u3011(\u672c\u793e:\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e:\u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79:\u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b\u3001³Ô¹Ï±¬ÁÏ)\u306f\u30012015 \u5e74 11 \u6708 2 \u65e5 \u6cbb\u9a13\u5206\u91ce\u3078\u5b8c\u5168\u306b\u30d1\u30c3\u30b1\u30fc\u30b8\u5316\u3055\u308c\u305f Start-Up \u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Vault Study Start-Up \u306b\u3088\u308a\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306f\u6cbb\u9a13\u7acb\u3061\u4e0a\u3052\u306b\u95a2\u9023\u3059\u308b\u30b3\u30f3\u30c6\u30f3\u30c4\u3068\u6d3b \u52d5\u3092\u7ba1\u7406\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u3053\u306e\u5305\u62ec\u7684\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u6cbb\u9a13\u95a2\u9023\u30b3\u30f3\u30c6\u30f3\u30c4\u3092\u3072\u3068\u3064\u306e\u30bd\u30fc\u30b9\u306b\u307e\u3068\u3081\u308b eTMF \u5229\u7528\u3067\u3001first patient enrollment \u307e\u3067\u306e\u6642\u9593\u3092\u77ed\u7e2e\u3057\u307e\u3059\u3002 \u307e\u305f\u3001\u624b\u4f5c\u696d\u306e\u30d7\u30ed\u30bb\u30b9\u3092\u81ea\u52d5\u5316\u3057\u3001\u30b9\u30e0\u30fc\u30ba\u306a\u76f8\u4e92\u904b\u7528\u6027\u3092\u5b9f\u73fe\u3057\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001 ³Ô¹Ï±¬ÁÏ \u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059)<\/p>\n
\u3000\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u306f\u3001\u9ad8\u5ea6\u306a\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u63a1\u7528\u3067\u9032\u6b69\u3092\u9042\u3052\u3001\u6cbb\u9a13\u30d7\u30ed\u30bb\u30b9\u306e\u69d8\u3005 \u306a\u5206\u91ce\u306b\u304a\u3044\u3066\u30b9\u30d4\u30fc\u30c9\u3084\u52b9\u7387\u3092\u4e0a\u3052\u3066\u3044\u307e\u3059\u30022015 TMF \u30ea\u30d5\u30a1\u30ec\u30f3\u30b9\u30e2\u30c7\u30eb\u30b5\u30fc\u30d9\u30a4\u306b \u3088\u308b\u3068\u3001\u56de\u7b54\u8005\u306e\u5927\u534a(61%)\u306f\u3001eTMF \u3092\u5229\u7528\u3057\u3066\u3044\u308b\u304b\u3001\u305d\u306e\u5229\u7528\u3092\u524d\u5411\u304d\u306b\u691c\u8a0e\u3057\u3066\u3044 \u307e\u3059\u3002\u307e\u305f ³Ô¹Ï±¬ÁÏ 2015 \u30da\u30fc\u30d1\u30fc\u30ec\u30b9 TMF \u30b5\u30fc\u30d9\u30a4\u306b\u3088\u308b\u3068\u3001\u56de\u7b54\u8005\u306e 56%\u304c\u3001\u6cbb\u9a13\u7acb\u3061\u4e0a \u3052\u306e\u30b9\u30d4\u30fc\u30c9\u30a2\u30c3\u30d7\u3092\u3001\u7d44\u7e54\u306b\u304a\u3051\u308b eTMF \u63a1\u7528\u306e\u4e3b\u306a\u4fc3\u9032\u8981\u7d20\u3068\u3057\u3066\u6319\u3052\u3066\u3044\u307e\u3059\u3002<\/p>\n
\u3000³Ô¹Ï±¬ÁÏ Vault Clinical \u62c5\u5f53\u30d0\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3001Kathryn King \u306f\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e \u3059\u3002\u300c\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306f\u3001\u6cbb\u9a13\u306b\u65bc\u3051\u308b\u7acb\u3061\u4e0a\u3052\u6642\u306e\u624b\u4f5c\u696d\u304b\u3064\u975e\u52b9\u7387\u7684\u306a\u30d7\u30ed\u30bb \u30b9\u306b\u9577\u3044\u9593\u60a9\u307e\u3055\u308c\u3066\u304d\u307e\u3057\u305f\u3002\u65e2\u5b58\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u3001\u66f8\u985e\u3042\u308b\u3044\u306f\u6d3b\u52d5\u30de\u30a4\u30eb\u30b9\u30c8 \u30fc\u30f3\u306e\u3044\u305a\u308c\u304b\u3092\u7ba1\u7406\u3067\u304d\u307e\u3057\u305f\u304c\u3001\u4e21\u65b9\u3092\u540c\u6642\u306b\u884c\u3046\u3053\u3068\u306f\u3042\u308a\u307e\u305b\u3093\u3067\u3057\u305f\u3002\u3053\u308c\u306f\u3001 \u7acb\u3061\u4e0a\u3052\u306e\u969b\u306e\u554f\u984c\u306b\u3064\u3044\u3066\u78ba\u8a8d\u3057\u53d6\u308a\u7d44\u3080\u4e0a\u3067\u91cd\u8981\u306a\u8ab2\u984c\u3068\u306a\u308a\u3001\u6cbb\u9a13\u671f\u9593\u3092\u9577\u5f15\u304b\u305b\u3001 \u5e02\u8ca9\u5316\u306b\u304b\u304b\u308b\u671f\u9593\u5168\u4f53\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u3066\u3044\u307e\u3057\u305f\u3002\u300d<\/p>\n
\u3000\u5f93\u6765\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u306f\u3001\u65bd\u8a2d\u306e\u7acb\u3061\u4e0a\u3052\u66f8\u985e\u4f5c\u6210\u3042\u308b\u3044\u306f\u958b\u59cb\u6d3b\u52d5\u30c7\u30fc\u30bf\u306e\u3044\u305a\u308c \u304b\u306b\u7126\u70b9\u3092\u5408\u308f\u305b\u308b\u3053\u3068\u3067\u3001\u3053\u306e\u554f\u984c\u3092\u60aa\u5316\u3055\u305b\u308b\u3070\u304b\u308a\u3067\u3001\u66f8\u985e\u3068\u30c7\u30fc\u30bf\u3092\u3072\u3068\u3064\u306b\u307e \u3068\u3081\u308b\u3053\u3068\u306f\u3067\u304d\u3066\u3044\u307e\u305b\u3093\u3067\u3057\u305f\u3002\u3055\u3089\u306b\u3053\u3046\u3057\u305f\u30b7\u30b9\u30c6\u30e0\u306e\u591a\u304f\u306f\u3001\u6cbb\u9a13\u5c65\u6b74\u306e\u4e00\u90e8 \u3068\u3057\u3066\u5f53\u8a72\u60c5\u5831\u3092\u540c\u69d8\u306b\u5fc5\u8981\u3068\u3059\u308b eTMF \u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u304b\u3089\u306f\u5207\u308a\u96e2\u3055\u308c\u3066\u3044\u307e\u3057\u305f\u3002 \u65ad\u7247\u5316\u3055\u308c\u305f\u74b0\u5883\u306f\u3001\u65bd\u8a2d\u306e\u7acb\u3061\u4e0a\u3052\u4e88\u5b9a\u3092\u9577\u5f15\u304b\u305b\u3066\u304a\u308a\u3001Tufts \u5927\u5b66\u533b\u85ac\u54c1\u958b\u767a\u7814\u7a76\u30bb\u30f3\u30bf \u30fc(CSDD)\u306e\u8abf\u3079\u306b\u3088\u308b\u3068\u3001\u9054\u6210\u307e\u3067\u306e\u30d7\u30ed\u30bb\u30b9\u306b\u5e73\u5747 17 \u30ab\u6708\u304b\u304b\u3063\u3066\u3044\u307e\u3057\u305f\u3002<\/p>\n
\u3000Tufts \u5927\u5b66\u533b\u5b66\u90e8 CSDD \u51c6\u6559\u6388 Ken Getz \u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u30b9\u30dd\u30f3\u30b5\u30fc\u3084 CRO \u306f\u901a\u5e38\u3001\u6cbb\u9a13\u7acb\u3061\u4e0a\u3052\u3084\u958b\u59cb\u6d3b\u52d5\u7ba1\u7406\u306e\u305f\u3081\u306b\u3001\u5358\u7d14\u3067\u3001\u5225\u3005\u306e\u3001\u4e92\u63db\u6027\u306e\u306a\u3044\u72ec\u81ea\u306b \u30ab\u30b9\u30bf\u30de\u30a4\u30ba\u3057\u305f\u30a2\u30d7\u30ed\u30fc\u30c1\u3084\u96fb\u5b50\u81e8\u5e8a\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u5229\u7528\u3057\u3066\u304d\u307e\u3057\u305f\u3002\u3053\u306e\u3053\u3068\u304c\u3001 \u6cbb\u9a13\u65bd\u8a2d\u3067\u306e\u696d\u52d9\u3084\u6d3b\u52d5\u306b\u983b\u7e41\u306b\u898b\u3089\u308c\u308b\u3001\u975e\u52b9\u7387\u6027\u3084\u4e00\u8cab\u6027\u306e\u306a\u3055\u306e\u4e00\u56e0\u3068\u306a\u3063\u3066\u3044\u307e \u3057\u305f\u3002\u300d<\/p>\n
\u3000Vault Study Start-Up \u306a\u3089\u3001\u65bd\u8a2d\u7acb\u3061\u4e0a\u3052\u66f8\u985e\u3084\u65bd\u8a2d\u958b\u59cb\u3092\u3001\u3072\u3068\u3064\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3 \u306b\u307e\u3068\u3081\u308b\u3053\u3068\u304c\u3067\u304d\u3001³Ô¹Ï±¬ÁÏ Vault eTMF \u3068\u306e\u30b9\u30e0\u30fc\u30ba\u306a\u76f8\u4e92\u904b\u7528\u6027\u3092\u3082\u305f\u3089\u3057\u307e\u3059\u3002\u3053 \u306e\u6a5f\u80fd\u306e\u7d44\u307f\u5408\u308f\u305b\u306b\u3088\u308a\u3001\u95a2\u9023\u30b3\u30f3\u30c6\u30f3\u30c4\u3084\u30c7\u30fc\u30bf\u306a\u3069\u3059\u3079\u3066\u306e Start-Up \u6d3b\u52d5\u306e\u771f\u5b9f\u3092 \u8a9e\u308b\u8cc7\u6599\u3092\u3001\u3072\u3068\u3064\u306b\u307e\u3068\u3081\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u65bd\u8a2d\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u3001CRO \u304c\u3001\u540c\u3058\u81e8\u5e8a\u60c5\u5831 \u306b\u30a2\u30af\u30bb\u30b9\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u9023\u643a\u3092\u7c21\u7d20\u5316\u3057\u3001\u52b9\u7387\u3092\u9ad8\u3081\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002Vault Study Start-Up \u306f\u307e\u305f\u3001\u5b8c\u5168\u3067\u78ba\u5b9f\u306a\u96fb\u5b50\u76e3\u67fb\u8a3c\u8de1\u306a\u3069\u3001\u7acb\u3061\u4e0a\u3052\u30d7\u30ed\u30bb\u30b9\u306e\u7ba1\u7406\u3092\u6539\u5584\u3059\u308b\u9ad8 \u5ea6\u306a\u6a5f\u80fd\u3082\u6709\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n
³Ô¹Ï±¬ÁÏ Systems \u793e\u306b\u3064\u3044\u3066<\/strong> Forward-looking Statements<\/strong> 2015\u5e7412\u670804\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e \u3000³Ô¹Ï±¬ÁÏ Systems Inc.\u3010NYSE:VEEV\u3011(\u672c\u793e:\u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e:\u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79:\u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b\u3001…<\/p>\n","protected":false},"author":129,"featured_media":37545,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322],"tags":[],"class_list":["post-37673","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","blog-product-veeva-vault"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/37673"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=37673"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/37673\/revisions"}],"predecessor-version":[{"id":37825,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/37673\/revisions\/37825"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=37673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=37673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=37673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n³Ô¹Ï±¬ÁÏ Systems \u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30ea\u30e5 \u30fc\u30b7 \u30e7\u30f3\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4 \u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067 300 \u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u3092\u64c1\u3057\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f \u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ \u306f\u3001\u30b5\u30f3\u30d5\u30e9 \u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55 \u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8 <\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in the company\u2019s filing on Form 10-Q for the period ended July 31, 2015. This is available on the company\u2019s website at http:\/\/www.veeva.com under the Investors section and on the SEC\u2019s website at www.sec.gov. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"